Post-Cycle Axis Recovery

Exogenous androgen suppresses the hypothalamic-pituitary-gonadal axis by negative feedback: GnRH pulsatility slows, LH and FSH fall towards undetectable, and LH-dependent Leydig cells go quiet while intratesticular testosterone collapses. Recovery runs the same sequence in reverse: gonadotropins first, Leydig output next, spermatogenesis last, since one spermatogenic cycle takes about 74 days before epididymal transit is added.

The most useful data come from male hormonal contraception research, not bodybuilding. A pooled analysis of those trials reported that most men regained a sperm concentration of 20 million per millilitre within six months of stopping, around ninety percent within a year, and nearly all by two years. Those were healthy volunteers on monitored regimens of limited duration. Prolonged supraphysiological use is associated with slower recovery and, in a minority, with persistent anabolic-steroid-induced hypogonadism.

The practical consequence is that time does most of the work, and that the dose and duration of suppression predict the outcome better than anything given afterwards. Serial morning testosterone measured with LH and FSH shows where recovery has reached, since the pairing separates a still-suppressed pituitary from a testis that is not responding. A single testosterone drawn a few weeks after cessation separates neither.

This is where the evidence departs from forum consensus. No regimen is approved as post-cycle therapy; the agents used off-label - hCG, selective estrogen receptor modulators, aromatase inhibitors - have not been compared against no treatment in randomised trials for this purpose, and a protocol circulated as established practice is not evidence. Restoring serum testosterone says nothing about fertility: intratesticular concentrations are an order of magnitude higher and are not what a blood test reports.